Reuters - Health Report

Click to View in Browser

Monday, May 8, 2017

Democrats criticize Senate's all-male healthcare group

WASHINGTON (Reuters) - U.S. Democrats on Sunday criticized the lack of women on a working group in the Republican-led Senate that will craft a plan to pass legislation to repeal and replace Obamacare.

Iowa Supreme Court blocks portion of 20-week abortion ban

(Reuters) - The Iowa Supreme Court on Friday granted an emergency temporary injunction halting a portion of a 20-week abortion ban that was signed into law by Republican Governor Terry Branstad just hours earlier.

How one U.S. state is leading the charge to dismantle Obamacare

FRANKFORT, Ky./SAN FRANCISCO (Reuters) - For nearly three years, Democrats and former President Barack Obama pointed to Kentucky as one of the Affordable Care Act’s biggest success stories.

Republican health bill stirs fear in opioid-wracked West Virginia

(Reuters) - Debra Bright said she battled for years with mental illness and addiction to pain pills and other drugs that were all too easy to find where she lives in West Virginia, one of the states hardest hit by the country's opiate epidemic.

Runners battling infections are less likely to finish a race

(Reuters Health) - Light, localized illnesses like a runny nose may not affect distance runners’ performance, but racing within days of an acute, systemic infection raises the odds of never finishing, researchers say.

GSK 'real world' drug test has second success in asthma

LONDON (Reuters) - GlaxoSmithKline notched up a second win for its pioneering "real world" approach to testing new drugs on Friday as its inhaled medicine Breo proved significantly better than standard care in helping people with asthma. The success of the 4,233-patient trial, which tested Breo in day-to-day practice across the town of Salford in northern England, follows a similar win for the medicine in chronic obstructive pulmonary disease (COPD) a year ago. The study showed the drug, w

FDA approves first ALS treatment in more than two decades

(Reuters) - The Food and Drug Administration on Friday approved Mitsubishi Tanabe Pharma Corp's treatment for fatal neurological disorder amyotrophic lateral sclerosis (ALS), marking the first such U.S. regulatory approval in more than two decades.

Type of prostate cancer surgery tied to later quality of life

(Reuters Health) - The quality of life men have after prostate cancer is influenced by the type of treatment they choose, a recent study confirms.

Can herbal remedies help kids with gastrointestinal issues?

(Reuters Health) - Many parents of children with debilitating gastrointestinal disorders may be frustrated by the lack of good treatment options and tempted to try herbal remedies at home, but a new study suggests they should proceed with caution.

Many eye care providers may not catch macular degeneration

(Reuters Health) - Primary care optometrists and ophthalmologists may sometimes fail to detect age-related macular degeneration, the most common cause of vision impairment in the elderly, a recent U.S. study suggests.